Episodes

  • Diabetes Dialogues | Ep. 1 | Cracking the T1D cure code: From breakthrough science to breakthrough access

    Diabetes Dialogues | Ep. 1 | Cracking the T1D cure code: From breakthrough science to breakthrough access
    Nov 19 2025
    This episode brings together Dr. Friedrich Mittermayer and Dr. Esther Latres PhD, VP of Research, to discuss the exciting cures for T1D, and the challenges those clinical trials face. This podcast episode explores the urgent realities and untapped opportunities in adult T1D diagnosis and treatment. From the heartbreak of misdiagnosis to the promise of cell and gene therapies, we spotlight the real-world journeys that shape clinical trial access and outcomes. You’ll hear how delayed diagnoses push young adults beyond critical trial windows, why older patients are often overlooked, and how new tools—from EMR pilots to genetic rescores—are helping us find the right patients, faster. With insights from Breakthrough T1D, we rally around a shared vision: a world without T1D. Because the future of diabetes care isn’t just about innovation—it’s about inclusion.
    Show More Show Less
    31 mins
  • Diabetes Dialogues | Ep. 2 | The critical first 100 days for pediatric Type 1 diabetes patients

    Diabetes Dialogues | Ep. 2 | The critical first 100 days for pediatric Type 1 diabetes patients
    Nov 19 2025
    This episode brings together Mala Puri, Senior Medical Director at Fortrea and Dr. Sanjoy Dutta PhD Chief Scientific Officer to discuss the unique challenges faced by pediatric populations in Type 1 diabetes clinical trials. We explore the specific needs and barriers for children and their families, and the role of advocacy and research groups in supporting them. The conversation highlights practical examples of support programs and tools that can help pediatric patients participate in clinical trials, ensuring their voices are heard and their needs are met.
    Show More Show Less
    25 mins